CareDx, Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
CareDx, Inc Stock Forecast and Price Target
The average price target of $12.50 for CareDx, Inc's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 65.34% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $15.00 and a low estimate of $10.00. Even if you are not interested in CDNA stock, you should still be aware of its competitors.
65.34% Upside
CareDx, Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, CareDx, Inc's Price has seen a drop from $20.96 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $8.13, which would mean an increase of 100.00%. Over the next seven years, experts predict that CareDx, Inc's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$573.60 | Buy/Sell | $591.94 | 7.22% |
| MCK Stock Forecast | McKesson Corp | Outperform |
11
|
$543.30 | Buy/Sell | $510.77 | 4.18% |
| VRSK Stock Forecast | Verisk Analytics | Outperform |
18
|
$221.14 | Buy/Sell | $250.89 | 15.76% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$198.40 | Buy/Sell | $241.28 | 21.47% |
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$134.26 | Buy/Sell | $141.17 | 8.00% |
CareDx, Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, CareDx, Inc's Revenue has grown by 45.86%, rising from $192.19M to $280.32M. According to 7 major analysts, CareDx, Inc's Revenue will fall by 15.99% in the next year, reaching $235.50M. Professionals believe that By 2030, CareDx, Inc's Revenue will fall to $270.09M– a 3.65% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ERF Stock Forecast | Eurofins Scientific | Hold |
18
|
56.64€ | Buy/Sell | 0.00€ | 5.93% |
| EXAS Stock Forecast | Exact Sciences | Buy |
8
|
$58.85 | Buy/Sell | $90.32 | 50.57% |
| NTRA Stock Forecast | Natera | Outperform |
7
|
$91.66 | Buy/Sell | $74.41 | 12.37% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$41.65 | Buy/Sell | $0.00 | 20.05% |
| SHL Stock Forecast | Sonic Healthcare | Hold |
18
|
$26.34 | Buy/Sell | $34.12 | 17.69% |
| ISS Stock Forecast | ISS A/S | Outperform |
9
|
kr130.70 | Buy/Sell | kr159.09 | 18.59% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CUZ Stock Forecast | Cousins Properties | Outperform |
16
|
$22.86 | Buy/Sell | $24.18 | 13.74% |
| GH Stock Forecast | Guardant Health | Buy |
6
|
$17.35 | Buy/Sell | $43.00 | 153.60% |
| NEO Stock Forecast | NeoGenomics | Outperform |
8
|
$14.14 | Buy/Sell | $20.09 | 41.44% |
CareDx, Inc EBITDA Forecast for 2023 - 2025 - 2030
CareDx, Inc's EBITDA has grown In the last three years, rising from $-15.52M to $-90.40M – a growth of 482.47%. In the following year, 5 experts forecast that CareDx, Inc's EBITDA will decrease by 53.57%, to $-41.97M. In 2030, professionals predict that CareDx, Inc's EBITDA will decrease by 109.82%, to $8.88M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$18.18 | Buy/Sell | $22.08 | 37.51% |
| VCYT Stock Forecast | Veracyte | Outperform |
11
|
$19.31 | Buy/Sell | $32.17 | 68.31% |
| OPK Stock Forecast | OPKO Health | Outperform |
8
|
$1.01 | Buy/Sell | $6.70 | 296.04% |
CareDx, Inc EBIT Forecast for 2023 - 2025 - 2030
CareDx, Inc's EBIT has seen impressive growth In the last three years, rising from $-22.53M to $-104.74M – a growth of 364.89%. In the next year, analysts believe that EBIT will reach $-116.68M – an increase of 11.40%. By 2030, professionals predict that CareDx, Inc's EBIT will decrease by 5.81%, to $-98.65M.
CareDx, Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, CareDx, Inc's EPS has seen a drop from $0.23 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $-0.92, which would mean an increase of 100.00%. Over the next seven years, experts predict that CareDx, Inc's EPS will grow at a rate of 100.00%.
.jpg)